Debt to Equity Ratio Chart

View Debt to Equity Ratio for VNRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 -0.3547
March 31, 2026 -0.366
December 31, 2025 -0.3348
September 30, 2025 -0.3251
June 30, 2025 -0.344
March 31, 2025 -0.2653
December 31, 2024 -0.2337
September 30, 2024 -0.2737
June 30, 2024 -0.2688
March 31, 2024 -0.3555
December 31, 2023 -0.7508
September 30, 2023 -2.107
June 30, 2023 0.8004
March 31, 2023 -2.041
December 31, 2022 -1.931
September 30, 2022 1.356
June 30, 2022 0.9136
March 31, 2022 0.4266
December 31, 2021 0.2239
September 30, 2021 0.1707
June 30, 2021 0.1488
March 31, 2021 0.1333
December 31, 2020 0.2718
September 30, 2020 0.1849
June 30, 2020 0.1865
Date Value
March 31, 2020 0.3994
December 31, 2019 0.2773
September 30, 2019 0.1809
June 30, 2019 0.2128
March 31, 2019 0.2101
December 31, 2018 0.269
September 30, 2018 0.2045
June 30, 2018 0.3165
March 31, 2018 0.1983
December 31, 2017 0.2782
September 30, 2017 0.1861
June 30, 2017 0.1347
March 31, 2017 0.0948
December 31, 2016 0.0695
September 30, 2016 0.0279
June 30, 2016 0.0242
March 31, 2016 0.0222
December 31, 2015 0.0631
September 30, 2015 0.0579
June 30, 2015 0.0649
March 31, 2015 0.00
December 31, 2014 4.285
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Abbott Laboratories 0.638
Align Technology, Inc. 0.0286
AngioDynamics, Inc. 0.0641
Accuray, Inc. 4.502
Alphatec Holdings, Inc. 52.37